|
| |
| | Schering UK: specialising in female healthcare, therapeutics, diagnostics and dermatology |
 | | The latest medical information on Schering's therapy areas, products, selected journal abstracts, information for patients and links to associated websites. | | | Direct access to the latest parliamentary briefings and newsletters on issues relating to Schering's products and therapy areas. | | | 24 hour access to press releases, contact information and fact sheets on Schering's products & therapy areas. |
|
http://www.schering.co.uk
(139 words)
|
|
| |
| | Schering-Plough Corporation and Richard J. Kogan: Admin. Proc. Rel. No. 34-48461 / September 9, 2003 |
| | At each of these meetings, through a combination of spoken language, tone, emphasis, and demeanor, Kogan disclosed negative and material, nonpublic information regarding Schering's earnings prospects, including that analysts' earnings estimates for Schering's 2002 third-quarter were too high, and that Schering's earnings in 2003 would significantly decline. | | | Schering subsequently reported actual EPS of $0.29 for the third quarter and $1.34 for the full 2002 fiscal year, while lowering its EPS guidance for the full 2003 fiscal year to a range of $0.75 to $0.85. | | | Finally, Schering disclosed that it expected U.S. wholesalers to deplete their prescription Claritin inventories by year end, with the majority being worked down in the third-quarter, and that it expected this to have an approximately $250 million negative impact on Schering's pretax profits for the remainder of 2002. |
|
http://www.sec.gov/litigation/admin/34-48461.htm
(3161 words)
|
|
| |
| | #523: 07-30-04 SCHERING-PLOUGH TO PAY $345 MILLION TO RESOLVE CRIMINAL AND CIVIL LIABILITIES FOR ILLEGAL MARKETING OF CLARITIN |
| | In the late 1990's, Schering Plough's powerhouse allergy drug, Claritin, faced growing competition. | | | Two of Schering Plough's largest managed care customers, Cigna Healthcare (Cigna) and Pacificare Health Systems (Pacificare), threatened to remove Claritin from their respective drug formularies in favor of the less expensive, Allegra, as a way to decrease their drug costs. | | | Schering Plough has agreed to pay a total of $292,969,482 arising from the allegations of fraud on the Medicaid program and PHS entities. |
|
http://www.usdoj.gov/opa/pr/2004/July/04_civ_523.htm
(1158 words)
|
|
| |
| | Schering-Plough - Wikipedia, the free encyclopedia |
| | Today Schering Plough manufactures several pharmaceutical drugs, the most well-known of which are the allergy drugs Claritin and Clarinex, and through a collaboration with Merck and Co., Zetia, an anti-cholesterol drug. | | | Schering Plough also owns and operates the major foot care brand name Dr. | | | Schering Plough was named one of the 100 Best Companies for Working Mothers in 2004 and 2005 by Working Mothers magazine. |
|
http://en.wikipedia.org/wiki/Schering_Plough
(444 words)
|
|
| |
| | Leerink Swann & Company Resumes Coverage of Schering-Plough Corporation (NYSE: SGP) |
| | Through internal research and collaborations with partners, Schering Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. | | | Schering Plough Corporation is a global science-based health care company with leading prescription, consumer and animal health products. | | | Schering Plough is headquartered in Kenilworth, New Jersey. |
|
http://www.leerink.com/news/20040625.htm
(195 words)
|
|
| |
| | C&EN: TODAY'S HEADLINES - Schering-Plough Awaits Indictment |
| | Schering-Plough says it has received a letter from the U.S. Attorney's Office for the District of Massachusetts advising the company that its subsidiary, Schering Corp., is the target of a federal grand jury investigation. | | | Schering says it has implemented changes to its sales, marketing, and clinical trial practices and is continuing to review those practices to ensure compliance with relevant laws and regulations. | | | The company says it "understands that, based on Department of Justice guidelines, receipt of a 'target' letter indicates the government intends to pursue an indictment and believes it has substantial evidence to support that indictment." |
|
http://pubs.acs.org/cen/topstory/8123/8123notw3.html
(120 words)
|
|
| |
| | Fool.com: Schering-Plough's Systemic Sickness [The Motley Fool Take] July 7, 2003 |
| | Allergy drug Claritin remains a major source of Schering's pain, as generic over-the-counter competition continues to eat away at U.S. sales. | | | With both Claritin and Intron/Rebetrol representing these two divisions, Schering's results appear increasingly vulnerable to the effects of increased competition. | | | And there's not much Schering can do to contain the damage. |
|
http://www.fool.com/news/take/2003/take030707.htm
(1755 words)
|
|
| |
| | Schering-Plough Corporation - Our Products |
| | Schering-Plough manufactures and markets prescription pharmaceuticals and animal health care products through our Schering-Plough Pharmaceuticals operating unit, which accounts for more than 85 percent of total company sales. | | | Marketed under the Schering Laboratories, Key Pharmaceuticals and Warrick Pharmaceuticals labels, prescription products are offered primarily in our five major therapeutic areas: respiratory products, anti-infective, oncology, dermatologicals and cardiovasculars. | | | Allergy and asthma products make up our largest and fastest growing therapeutic category, with $1.8 billion in worldwide sales in 1995. |
|
http://www.tumble.com/demo_area/s-p/about1.htm
(551 words)
|
|
| |
| | Schering-Plough Research Institute - An Overview of Schering-Plough Corporation |
| | Schering Corporation, now a global research-based pharmaceutical firm, merges with Plough, Inc. Headquartered in Memphis, Tenn. Plough, Inc. -- a mass merchandiser of popular consumer products -- was founded in 1908 and had evolved into a worldwide company. | | | Based on CHLOR-TRIMETON, Schering develops CORICIDIN (chlorpheniramine maleate and aspirin), a prescription drug for the relief of cold symptoms. | | | Schering discovers and develops EULEXIN (flutamide), the first non-steroidal antiandrogen effective against prostatic cancer. |
|
http://www.tumble.com/demo_area/s-p/corpcen.htm
(1057 words)
|
|
| |
| | Schering Hepatitis Innovations: Hepatitis A, B, C symptoms and treatments. |
| | Schering Hepatitis Innovations: Hepatitis A, B, C symptoms and treatments. | | | The Be In Charge® Program is a free, personal support service for chronic hepatitis C patients sponsored by Schering Corporation. | | | Learn more about this treatment and the easy-to-use |
|
http://www.hepatitisinnovations.com
(126 words)
|
|
| |
| | Schering Plough |
| | Schering Plough is a worldwide pharmaceutical and animal health company. | | | Home > HLS > HLS Clients > Schering Plough | | | The following extract from Michelle Rokke’s diaries refer to Schering Plough's involvment with HLS. |
|
http://www.shac.net/HLS/clients/profiles/plough.html
(473 words)
|
|
| |
| | Forbes.com: Dog Watch: Schering-Plough |
| | Seiden thinks that if Schering can ramp out Clarinex before springtime of 2002--next year's hayfever season--they can switch many patients over. | | | Problems are rarely solved over night--but there have been more than 130 nights for Schering to attack this one. | | | A week ago, Schering said the FDA had cited continuing problems at the plants. |
|
http://www.forbes.com/2001/06/29/0629dog.html
(636 words)
|
|
| |
| | Moody's Cuts Schering-Plough |
| | Schering has a lot riding on Vytorin, which is expected to be approved by the Food and Drug Administration sometime this month. | | | Specifically, Moody's said it was concerned about the launch of Vytorin, a cholesterol fighter created by combining Schering's Zetia and Merck's (MRK:NYSE - news - research) Zocor into a single pill. | | | Given the uncertainty around Schering's ability to produce free cash flow going forward, Moody's said its outlook was negative. |
|
http://www.thestreet.com/stocks/biotech/10171091.html
(310 words)
|
|
| |
| | SchoolAsthmaAllergy.com |
| | Schering employees consistently demonstrate their commitment to their communities by donating time to the Schering-Plough Cares volunteer program, including pro bono legal work, student mentoring, and consultations to non-profit organizations. | | | Schering-Plough is more than just a company—it's a company of caring individuals. |
|
http://www.schoolasthmaallergy.com
(71 words)
|
|
| |
| | Schering Corporation - New Jersey ( Now Schering-Plough ) |
| | For Schering, the 1950s and 1960s were characterized by continued growth, attributable to research and development and acquisition activities. | | | This historic document was printed by the Security-Columbian Banknote Company and has an ornate border around it with a vignette of two allegorical people sitting with their medical equipment next to the Schering company logo. | | | Schering Corporation was first established in the late 1800s as the U.S. subsidiary of Schering AG, a German-based pharmaceutical and chemical company. |
|
http://www.scripophily.net/scconewje19.html
(550 words)
|
|
| |
| | Welcome to Schering International |
| | Schering AG and Schering-Plough are linked together by Ernst Schering (1824 - 1889), the founder of both companies. | | | Welcome to the joint web site of Schering AG and Schering-Plough. | | | Today however, the companies are completely independent and not associated with each other in any way. |
|
http://www.schering.com
(62 words)
|
|
| |
| | Customer Success Story: Schering Plough |
| | The company is an integral part of the Schering-Plough Essex Spa Group, home to brand names such as Polaramin and NeoCoricidin, as well as important skin care and cosmetic products. | | | Schering Plough has been present in Italy since the early 1960's with offices in Milan, Comazzo (its pharmaceutical production factory), as well as its Research Centre in the San Raffaele Biomedical Science Park in Milan. | | | Schering Plough is one of the largest international companies in the pharmaceutical sector, in terms of size and turnover. |
|
http://www.legato.com/about_us/success/success_Schering.htm
(184 words)
|
|
| |
| | Schering Plough News |
| | Schering Plough News continually updated from thousands of sources around the net. | | | Centocor and Shering - Plough Next-Generation Biologic Shows Promise... | | | Roche and Timeris, which currently market the only approved fusion inhibitor Fuzeon, are developing two next-generation fusion inhibitor peptides with a dual goal: achieving durable suppression of HIV and... |
|
http://www.topix.net/com/sgp
(850 words)
|
|
| |
| | Zetia Schering Plough / Side Effects Of Zetia / Retrovir |
| | Zetia Schering Plough / Side Effects Of Zetia / Retrovir | | | Schering-Plough Forward Looking Statement The information in this press release... | | | Schering Plough Schering-Plough Corporation is a pharmaceutical company started in |
|
http://zetia.pharmacy-world.biz/zetia_schering_plough
(810 words)
|
|
| |
| | SCHERING PLOUGH SIGNS CONSENT DECREE WITH FDA AGREES TO PAY $500 MILLION |
| | FDA today announced that Schering-Plough Corporation, its subsidiary Schering-Plough Products, LLC, and two principal corporate officers have signed a consent decree of permanent injunction agreeing to measures to assure that the drug products manufactured at the firms' New Jersey and Puerto Rico plants are made in compliance with FDA's current good manufacturing practice regulations ("CGMP"). | | | For at least five years after entry of the injunction, the companies must conduct regular audits of its operations and make reports to FDA concerning its continuing compliance, and FDA will periodically inspect Schering's manufacturing operations to evaluate the regulatory status of those operations. | | | Schering agreed to pay a record five hundred million dollars to the U.S. Treasury after the consent decree has been entered by the court. |
|
http://www.fda.gov/bbs/topics/NEWS/2002/NEW00809.html
(437 words)
|
|
| |
| | Schering-Plough Aquaculture: Disease Control in Farmed Fish |
| | Schering-Plough Animal Health Corporation is the worldwide animal health business of Schering-Plough Corporation, a research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide. | | | Schering-Plough Animal Health Launches New Web Site for AQUAFLOR (florfenicol) in U.S. Schering Plough Animal Health Receives EU approval of Vaccine for Protection of Rainbow Trout from Enteric Red Mouth Disease (Yersiniosis) |
|
http://www.spaquaculture.com
(79 words)
|
|
| |
| | Public Citizen Congress Watch Congress Watch - Can Schering-Plough's Aggressive Lobbying Buy a Claritin Patent Extension? |
| | Though not registered specifically as a Schering-Plough lobbyist, the Senate Minority Leader's wife is a registered lobbyist for Baker, Donelson, Bearman and Caldwell, Schering's leading outside lobbying firm. | | | He is well connected with Judiciary Committee members which must first approve patent extension legislation. | | | According to staff accounts, she has personally lobbied members of the House Judiciary Committee on H.R. Jack Martin |
|
http://www.citizen.org/congress/reform/archives/claritin/articles.cfm?ID=1076
(1685 words)
|
|
| |
| | Schering-Plough Corporation |
| | 08:38 ET Schering Laboratories Begins CLARINEX(R) DTC Education Program |
|
http://www.prnewswire.com/comp/777050.html
(5526 words)
|
|
| |
| | Schering-Plough - Wikipedia, the free encyclopedia |
| | Today Schering Plough manufactures several pharmaceutical drugs, the most well-known of which are the allergy drugs Claritin and Clarinex, and through a collaboration with Merck and Co., Zetia, an anti-cholesterol drug. | | | As of June 2005, Schering Plough has 1.4% market share in the U.S., placing it at #17 in the top 20 pharmaceutical corporations by sales compiled by IMS Health. | | | In 1971, the Schering Corporation merged with Plough to form Schering Plough. |
|
http://en.wikipedia.org/wiki/Schering_Plough
(375 words)
|
|
| |
| | Prescription-Drugs-Lawsuits: K-Dur20 Litigation |
| | Allocated the entire market for 20 milliequivalent, extended-release potassium chloride supplements to Schering-Plough, with a portion of Schering-Plough's monopoly profits being allocated to Upsher-Smith and AHP in exchange for their agreement not to compete with Schering-Plough; and | | | Although there are several companies that manufacture potassium chloride supplements, Schering-Plough is the only manufacturer of 20 milliequivalent ("MEQ"), extended-release potassium chloride tablets and capsules. | | | The lawsuits filed by Lieff Cabraser in June 2001 on behalf of consumers and consumer advocacy groups allege that Schering-Plough, Upsher-Smith and AHP have: |
|
http://www.prescription-drugs-lawsuits.com/k-dur.htm
(375 words)
|
|
| |
| | Schering plough nj |
| | KENILWORTH, NJ, Jan. 3 /PRNewswire-FirstCall/ -- Schering-Plough is based in Kenilworth, NJ, and its Web site is http://www.schering-plough.com. | | | That strategy helped the Nutley, NJ, company grab half the market in barely a year from Schering-Plough Corp., of Kenilworth, NJ, which had nearly a | | | KENILWORTH, NJ, Jan. 5 /PRNewswire-FirstCall/ -- Schering-Plough is based in Kenilworth, NJ, and its Web site is http://www.schering-plough.com. |
|
http://merck.allworldsites.com/q/merck-schering-plough-nj.htm
(1039 words)
|
|
| |
| | SignOnSanDiego.com > News > Business -- Bayer announces strategic pharmaceuticals alliance with Schering-Plough |
| | Bayer and Schering-Plough will share Bayer's portion of the U.S. sales profits of Levitra in exchange for Schering-Plough's promotion of the drug. | | | Schering-Plough will also undertake on Bayer's behalf the U.S. commercialization activities for the erectile dysfunction drug Levitra, which is marketed under a co-promotion agreement with GlaxoSmithKline. | | | BERLIN – German chemical and drug maker Bayer AG announced Monday it has entered a strategic alliance with the Schering-Plough Corp. that will have the New Jersey-based company market and distribute Bayer's primary care pharmaceutical products in the United States and Puerto Rico. |
|
http://www.signonsandiego.com/news/business/20040913-0612-germany-bayer-schering.html
(1039 words)
|
|
| |
| | HeartCenterOnline: |
| | Although the study sponsored by Merck and Schering-Plough was designed to monitor LDL reduction, researchers observed greater increases in levels of HDL, or good cholesterol, in the Vytorin patients -- 9 percent versus 3.8 percent at 40 mg. | | | Mar 09 (Reuters) - A combination medicine by Merck & Co. and Schering-Plough Corp. was more effective in helping high-risk patients achieve stringent, new lower cholesterol goals than Pfizer Inc.'s top- selling Lipitor in a clinical trial. | | | Vytorin, which was approved for sale in the United States last July, combines Merck's popular cholesterol fighter Zocor with Zetia, a Merck and Schering-Plough drug that uses a different mechanism to lower LDL levels than the statins. |
|
http://heart.healthcentersonline.com/newsstories/vytorintopslipitorinhighrisk.cfm
(1039 words)
|
|
|
